You are here

Articles

Posted on Thursday, September 13, 2007 - 5:37pm
The Health-EU Portal started issuing last week a multilingual newsletter, which aims to better inform European citizens on what is going on in the field of health at European and international level.
Posted on Thursday, September 13, 2007 - 2:25pm
Chronic myeloid leukaemia (CML) can be considered as a paradigm for neoplasias that evolve through a multi-step process. CML is also one of the best examples of a disease that can be targeted by molecular therapy;...
Posted on Wednesday, May 9, 2007 - 2:03pm
Dasatinib (Sprycel) is accepted for restricted use for the treatment of adults with chronic myeloid leukaemia (CML) with resistance or intolerance to prior therapy including imatinib mesylate...
Posted on Wednesday, April 25, 2007 - 1:54pm
Interesting article on mechanisms of resistance Imatinib more....
Posted on Wednesday, April 25, 2007 - 1:49pm
The current recommended first line therapy for newly diagnosed patients with CML is IM. However, despite the impressive responses achieved in the majority of patients, problems remain...
Posted on Sunday, December 10, 2006 - 6:47pm
Summary perspective of the 5th Annual CML Conference in Manchester on 6th/7th October Firstly, it is worth note that having attended the last 3 of these conferences, we feel that there has been a continual improvement...
Posted on Monday, September 25, 2006 - 7:11am
Every EU citizen should fully understand the importance of this document because one in three of us will contract cancer over our lifetime and one in four of us will die from it. Cancer is a disease type that will...
Posted on Tuesday, September 19, 2006 - 4:19pm
A race against time... Patients' clamour for Gleevec began in spring 1999, as soon as the results of the first tests on CML patients spread. Thanks to the Internet they were aware of the drug from its early stages.
Posted on Saturday, September 9, 2006 - 3:45am
<IMG class="topleft" src="http://www.cmlsupport.org.uk/gfx/llambook.jpg" alt="image of book"></IMG>A practical...
Posted on Saturday, July 22, 2006 - 4:14am
(CML) is a form of chronic leukemia characterized by increased production of myeloid cells in the bone marrow. It is a type of myeloproliferative disease...